Jump to content

Blood Clot Risk - UK's health chiefs today recommended AstraZeneca's vaccine shouldn't be given to under-30s


Bigbird

Recommended Posts

UK's health chiefs today recommended AstraZeneca's vaccine shouldn't be given to under-30s because of its link to potentially deadly blood clots.

 

Britons were once again left with a raft of questions over the safety of AstraZeneca's coronavirus vaccine after health chiefs today recommended it should not be given to under-30s because of its link to potentially deadly blood clots.

No10's jab advisory panel says healthy people aged 18 to 29 be offered either Pfizer or Moderna's vaccine instead, when the programme moves to younger groups in the coming months.

The Government, opposition politicians and medical experts tonight rushed to shore up confidence in AstraZeneca's vaccine, insisting that it was safe and the benefits far outweighed any risks for the vast majority.  

Here MailOnline answers all of your questions about AstraZeneca's jab, revealing why it is safe for you to still get your second dose and what the alternatives are for under-30s. 

 

41472840-9446173-image-a-3_1617836560771
 
The EMA, which polices the safety of drugs used on the continent, spotted 169 cases of cerebral vein thrombosis (CVST) and 53 cases of splanchnic vein thrombosis (SVT), from 34million jabs. CVST occurs when a vein that drains blood from the brain is blocked by a clot. It can lead to a stroke. SVT is the same type of blood clot but it occurs in the digestive system
 

The EMA, which polices the safety of drugs used on the continent, spotted 169 cases of cerebral vein thrombosis (CVST) and 53 cases of splanchnic vein thrombosis (SVT), from 34million jabs. CVST occurs when a vein that drains blood from the brain is blocked by a clot. It can lead to a stroke. SVT is the same type of blood clot but it occurs in the digestive system

WHAT HAS HAPPENED? 

The Joint Committee on Vaccination and Immunisation (JCVI) has advised that healthy adults aged 18-29 are offered an alternative vaccine to the Oxford/AstraZeneca jab, if available.

The recommendation follows a review by the UK’s medicines regulator, the MHRA, which found there was a ‘strong possibility’ that very rare blood clots, known as cerebral venous sinus thrombosis (CVST), could be caused by the vaccine.

Dr June Raine, chief executive of the MHRA, yesterday said the possible side effect was ‘extremely rare’, while the balance of benefits from having the jab are ‘still very favourable for the majority of people’. However, for healthy younger adults, for which the risk from coronavirus is far lower, it is more ‘finely balanced’.

 

read the rest

https://www.dailymail.co.uk/news/article-9446173/Covid-19-UK-Ive-AstraZeneca-jab.html

  • Like 2
  • Wahaha 1
Link to comment
Share on other sites

simple logic, if the vaccines r not even tested on monkeys, how to know they r effective and safe for human?????

 

nb, i think they didnt even test it on lab mices.

 

if they did, some of these adverse reactions shld have been detected.

 

song bo, PETA??????

 

wahahahahaha

  • Wahaha 1
Link to comment
Share on other sites

On 4/9/2021 at 7:59 AM, socrates469bc said:

simple logic, if the vaccines r not even tested on monkeys, how to know they r effective and safe for human?????

 

nb, i think they didnt even test it on lab mices.

 

if they did, some of these adverse reactions shld have been detected.

 

song bo, PETA??????

 

wahahahahaha

 

yes they're now experimenting on humans. The horror! 

  • Like 1

Good content = Topics that genuinely encourages and stimulates interaction/banter. 

 

Bad content = Clickbaits, brag posts and social media news feed that nobody gives a flying fuck about + waste of server storage space

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...

Important Information

Mugentech.net uses cookies to ensure you get the best experience on our website. By using this site you agree to Privacy Policy